| Glutaminase activity determines cytotoxicity of L-asparaginases on most leukemia cell lines JH Parmentier, M Maggi, E Tarasco, C Scotti, VI Avramis, SD Mittelman Leukemia research 39 (7), 757-762, 2015 | 105 | 2015 |
| A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro M Maggi, SD Mittelman, JH Parmentier, G Colombo, M Meli, JM Whitmire, ... Scientific reports 7 (1), 14479, 2017 | 55 | 2017 |
| Anti-cancer auto-antibodies: Roles, applications and open issues H de Jonge, L Iamele, M Maggi, G Pessino, C Scotti Cancers 13 (4), 813, 2021 | 35 | 2021 |
| Engineering of Helicobacter pylori L-Asparaginase: Characterization of Two Functionally Distinct Groups of Mutants M Maggi, LR Chiarelli, G Valentini, C Scotti PLoS One 10 (2), e0117025, 2015 | 32 | 2015 |
| A new variant of phosphoglycerate kinase deficiency (p. I371K) with multiple tissue involvement: molecular and functional characterization E Fermo, P Bianchi, LR Chiarelli, M Maggi, GML Mandarà, C Vercellati, ... Molecular Genetics and Metabolism 106 (4), 455-461, 2012 | 30 | 2012 |
| Enzymes in metabolic anticancer therapy M Maggi, C Scotti Therapeutic Enzymes: Function and Clinical Implications, 173-199, 2019 | 28 | 2019 |
| The phosphoglycerate kinase 1 variants found in carcinoma cells display different catalytic activity and conformational stability compared to the native enzyme A Fiorillo, M Petrosino, A Ilari, A Pasquo, A Cipollone, M Maggi, ... PLoS One 13 (7), e0199191, 2018 | 25 | 2018 |
| Insights into human phosphoglycerate kinase 1 deficiency as a conformational disease from biochemical, biophysical, and in vitro expression analyses AL Pey, M Maggi, G Valentini Journal of inherited metabolic disease 37, 909-916, 2014 | 21 | 2014 |
| In Vitro Evaluation of the Biological Availability of Hyaluronic Acid Polyethylene Glycols‐Cross‐Linked Hydrogels to Bovine Testes Hyaluronidase N Zerbinati, R Mocchi, H Galadari, C Maccario, M Maggi, R Rauso, ... BioMed Research International 2019 (1), 3196723, 2019 | 20 | 2019 |
| Enhanced expression and purification of camelid single domain VHH antibodies from classical inclusion bodies M Maggi, C Scotti Protein Expression and Purification 136, 39-44, 2017 | 19 | 2017 |
| Protein stability, folding and misfolding in human PGK1 deficiency G Valentini, M Maggi, AL Pey Biomolecules 3 (4), 1030-1052, 2013 | 19 | 2013 |
| Biochemistry of lipolytic enzymes secreted by Penicillium solitum and Cladosporium cladosporioides S Chinaglia, LR Chiarelli, M Maggi, M Rodolfi, G Valentini, AM Picco Bioscience, biotechnology, and biochemistry 78 (2), 245-254, 2014 | 17 | 2014 |
| Radiation tests of real-sized prototype RPCs for the Phase-2 Upgrade of the CMS Muon System KS Lee, SW Cho, SY Choi, B Hong, Y Go, MH Kang, JH Lim, SK Park, ... Journal of Instrumentation 11 (08), C08008, 2016 | 10 | 2016 |
| High resolution structure of human apolipoprotein (a) kringle IV type 2: beyond the lysine binding site A Santonastaso, M Maggi, H De Jonge, C Scotti Journal of lipid research 61 (12), 1687-1696, 2020 | 9 | 2020 |
| Revealing Escherichia coli type II l-asparaginase active site flexible loop in its open, ligand-free conformation M Maggi, M Meli, G Colombo, C Scotti Scientific reports 11 (1), 18885, 2021 | 7 | 2021 |
| Tackling Critical Catalytic Residues in Helicobacter pylori l-Asparaginase M Maggi, LR Chiarelli, G Valentini, C Scotti Biomolecules 5 (2), 306-317, 2015 | 7 | 2015 |
| SerpinB3 upregulates low-density lipoprotein receptor-related protein (LRP) family members, leading to Wnt signaling activation and increased cell survival and invasiveness S Quarta, A Cappon, C Turato, M Ruvoletto, S Cannito, G Villano, ... Biology 12 (6), 771, 2023 | 5 | 2023 |
| High rate capability studies of triple-GEM detectors for the ME0 upgrade of the CMS muon spectrometer M Bianco, F Fallavollita, F Fiorina, M Maggi, A Pellecchia, LFR Garcia, ... Journal of Instrumentation 17 (02), C02009, 2022 | 5 | 2022 |
| A targeted catalytic nanobody (T-CAN) with asparaginolytic activity M Maggi, G Pessino, I Guardamagna, L Lonati, C Pulimeno, C Scotti Cancers 13 (22), 5637, 2021 | 4 | 2021 |
| Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets G Pessino, C Scotti, M Maggi, Immuno-HUB Consortium Cancers 16 (5), 901, 2024 | 3 | 2024 |
